RIOK3 potentially regulates osteogenesis-related pathways in ankylosing spondylitis and the differentiation of bone marrow mesenchymal stem cells
Genomics · 2023
DOI: 10.1016/j.ygeno.2023.110730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genomics, 2023. Verfasst von He-Xiang Zong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, the First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Spondylitis, Ankylosing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wu Jieping Medical Foundation.
Abstract (Originalsprache)
RNA-binding proteins (RBPs), which are key effectors of gene expression, play critical roles in inflammation and immune regulation. However, the potential biological function of RBPs in ankylosing spondylitis (AS) remains unclear. We identified differentially expressed genes (DEGs) in peripheral blood mononuclear cells (PBMCs) of five patients with AS and three healthy persons by RNA-seq, obtained differentially expressed RBPs by overlapping DEGs and RBPs summary table. RIOK3 was selected as a target RBP and knocked down in mouse bone marrow mesenchymal stem cells (mBMSCs), and transcriptomic studies of siRIOK3 mBMSCs were performed again using RNA-seq. Results showed that RIOK3 knockdown inhibited the expression of genes related to osteogenic differentiation, ribosome function, and β-interferon pathways in mBMSCs. In vitro experiments have shown that RIOK3 knockdown reduced the osteogenic differentiation ability of mBMSCs. Collectively, RIOK3 may affect the differentiation of mBMSCs and participate in the pathogenesis of AS, especially pathological bone formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Rheumatology and Immunology, the First Affiliated Hospital of Anhui Medical University, Hefei, China. Electronic address: xsqian-1112@163.com.
Förderung
- Wu Jieping Medical Foundation
Zitieren
APA
Zong, H. X., Liu, Y. Q., Wang, X. L., Miao, J. Y., Luo, L. P., Wang, J. X., Chu, Y. R., Tong, W. Q., Zhao, X., & Xu, S. Q. (2023). RIOK3 potentially regulates osteogenesis-related pathways in ankylosing spondylitis and the differentiation of bone marrow mesenchymal stem cells. Genomics. https://doi.org/10.1016/j.ygeno.2023.110730
Vancouver
Zong HX, Liu YQ, Wang XL, Miao JY, Luo LP, Wang JX, et al. RIOK3 potentially regulates osteogenesis-related pathways in ankylosing spondylitis and the differentiation of bone marrow mesenchymal stem cells. Genomics. 2023. doi:10.1016/j.ygeno.2023.110730
BibTeX
@article{Zong2023,
author = {Zong, He-Xiang and Liu, Ya-Qian and Wang, Xi-le and Miao, Jie-Yu and Luo, Li-Ping and Wang, Jian-Xiong and Chu, Yi-Ran and Tong, Wan-Qiu and Zhao, Xu and Xu, Sheng-Qian},
title = {RIOK3 potentially regulates osteogenesis-related pathways in ankylosing spondylitis and the differentiation of bone marrow mesenchymal stem cells},
journal = {Genomics},
year = {2023},
doi = {10.1016/j.ygeno.2023.110730}
}
EUVIMED